Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. (Q45394726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

title

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Constatino III Roberto López Macías

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

Constatino III Roberto López Macías

8 January 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

12

Guy Boivin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

7

Yacine Abed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

Jerome Alexandre Denis

1

object named as

Jérôme Denis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

Elizabeth Acosta-Ramirez

2

object named as

Elizabeth Acosta-Ramirez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

8

Christian Savard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

4

Marie-Eve Hamelin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Yinghi Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

Irena Koukavica

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

Mariana Baz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

Christine Pare

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

Denis Leclerc

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

12 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

issue

27-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

3395-3403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18511159 AND SRC:MED&resulttype=core&format=json

A "universal" human influenza A vaccine

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Unpacking the incoming influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Purification and biochemical characterization of a monomeric form of papaya mosaic potexvirus coat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Aluminium adjuvants--in retrospect and prospect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Specific cellular stimulation in the primary immune response: experimental test of a quantized model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Cell biology of antigen processing in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Cross-priming of T cell responses by synthetic microspheres carrying a CD8 T cell epitope requires an adjuvant signal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Use of viral vectors for vaccine production in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Development of effective vaccines against pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052

Influenza and the challenge for immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2008.04.052